| Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple … EA Mittendorf, H Zhang, CH Barrios, S Saji, KH Jung, R Hegg, A Koehler, ... The Lancet 396 (10257), 1090-1100, 2020 | 781 | 2020 |
| Estrogen receptor (ER) β, a modulator of ERα in the uterus Z Weihua, S Saji, S Mäkinen, G Cheng, EV Jensen, M Warner, ... Proceedings of the National Academy of Sciences 97 (11), 5936-5941, 2000 | 696 | 2000 |
| Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 … SM Swain, D Miles, SB Kim, YH Im, SA Im, V Semiglazov, E Ciruelos, ... The Lancet Oncology 21 (4), 519-530, 2020 | 595 | 2020 |
| A role for estrogen receptor β in the regulation of growth of the ventral prostate Z Weihua, S Mäkelä, LC Andersson, S Salmi, S Saji, JI Webster, ... Proceedings of the National Academy of Sciences 98 (11), 6330-6335, 2001 | 540 | 2001 |
| Estrogen receptors α and β in the rodent mammary gland S Saji, EV Jensen, S Nilsson, T Rylander, M Warner, JÅ Gustafsson Breast Cancer Research 2, 1-1, 2000 | 494 | 2000 |
| Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—a meta‐analysis R Suzuki, N Orsini, S Saji, TJ Key, A Wolk International journal of cancer 124 (3), 698-712, 2009 | 392 | 2009 |
| Significant correlation of monocyte chemoattractant protein‐1 expression with neovascularization and progression of breast carcinoma H Saji, M Koike, T Yamori, S Saji, M Seiki, K Matsushima, M Toi Cancer: Interdisciplinary International Journal of the American Cancer …, 2001 | 385 | 2001 |
| Estrogen receptor beta in breast cancer. C Palmieri, GJ Cheng, S Saji, M Zelada-Hedman, Z Weihua, ... Endocrine-related cancer 9 (1), 1-13, 2002 | 343 | 2002 |
| Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer S Saji, M Kawakami, S Hayashi, N Yoshida, M Hirose, S Horiguchi, A Itoh, ... Oncogene 24 (28), 4531-4539, 2005 | 338 | 2005 |
| Estrogen receptors and proliferation markers in primary and recurrent breast cancer EV Jensen, G Cheng, C Palmieri, S Saji, S Mäkelä, S Van Noorden, ... Proceedings of the National Academy of Sciences 98 (26), 15197-15202, 2001 | 311 | 2001 |
| Clinical importance of estrogen receptor-β evaluation in breast cancer patients treated with adjuvant tamoxifen therapy N Honma, R Horii, T Iwase, S Saji, M Younes, K Takubo, M Matsuura, ... Journal of clinical oncology 26 (22), 3727-3734, 2008 | 306 | 2008 |
| A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary G Cheng, Z Weihua, S Mäkinen, S Mäkelä, S Saji, M Warner, ... Biology of reproduction 66 (1), 77-84, 2002 | 205 | 2002 |
| Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study R Suzuki, W Ye, T Rylander-Rudqvist, S Saji, GA Colditz, A Wolk Journal of the National Cancer Institute 97 (21), 1601-1608, 2005 | 198 | 2005 |
| Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status—a meta‐analysis of epidemiological studies R Suzuki, N Orsini, L Mignone, S Saji, A Wolk International Journal of Cancer 122 (8), 1832-1841, 2008 | 194 | 2008 |
| Clinical significance of estrogen receptor β in breast cancer S Saji, M Hirose, M Toi Cancer chemotherapy and pharmacology 56, 21-26, 2005 | 175 | 2005 |
| A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients E Suzuki, R Niwa, S Saji, M Muta, M Hirose, S Iida, Y Shiotsu, M Satoh, ... Clinical cancer research 13 (6), 1875-1882, 2007 | 174 | 2007 |
| Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis N Niikura, N Hayashi, N Masuda, S Takashima, R Nakamura, ... Breast cancer research and treatment 147, 103-112, 2014 | 165 | 2014 |
| Expression of estrogen receptor (ER) βcx protein in ERα-positive breast cancer: specific correlation with progesterone receptor S Saji, Y Omoto, C Shimizu, M Warner, Y Hayashi, S Horiguchi, ... Cancer Research 62 (17), 4849-4853, 2002 | 165 | 2002 |
| Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure K Takemoto, E Hatano, K Iwaisako, M Takeiri, N Noma, S Ohmae, ... FEBS open bio 4, 777-787, 2014 | 163 | 2014 |
| MDM2 enhances the function of estrogen receptor α in human breast cancer cells S Saji, N Okumura, H Eguchi, S Nakashima, A Suzuki, M Toi, Y Nozawa, ... Biochemical and biophysical research communications 281 (1), 259-265, 2001 | 142 | 2001 |
